0 Bewertungen
ID

37107

Beschreibung

Study ID: 102146 Clinical Study ID: SUM102146 Study Title: An open-label, randomized, three-period crossover study to demonstrate the bioequivalence of sumatriptan 4 mg STATdose to IMITREX™ 6 mg STATdose after dose-normalization, and to assess the relative bioavailability of 4 mg sumatriptan injected using the STATdose device compared to 4 mg sumatriptan injected manually Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran Study Indication: Migraine Disorders

Stichworte

Versionen (1)
  1. 03.07.19 03.07.19 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

3. Juli 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Bioequivalence of Sumatriptan 4 mg STATdose to IMITREX™ 6 mg STATdose; 102146

    Englisch

    Concomitant Medication

    1 Formulare  
    1. StudyEvent: ODM
      1. Concomitant Medication
    Administrative Data
    Beschreibung

    Administrative Data

    Alias
    UMLS CUI-1
    C1320722 (Administrative documentation)
    SNOMED
    405624007
    Subject number
    Beschreibung

    Clinical Trial Subject Unique Identifier

    Datentyp

    integer

    Alias
    UMLS CUI [1]
    C2348585 (Clinical Trial Subject Unique Identifier)
    Concomitant Medications
    Beschreibung

    Concomitant Medications

    Alias
    UMLS CUI-1
    C2347852 (Concomitant Agent)
    Were any concomitant medications taken by the subject during the study?
    Beschreibung

    Concomitant Agent, During, Clinical Trials

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0347984 (During)
    SNOMED
    371881003
    UMLS CUI [1,3]
    C0008976 (Clinical Trials)
    SNOMED
    110465008
    LOINC
    LP231796-6
    Drug (Trade name preferred)
    Beschreibung

    Concomitant Agent, Medication name

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C2360065 (Medication name)
    LOINC
    MTHU027854
    Dose
    Beschreibung

    Concomitant Agent, Medication dose

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C3174092 (Medication dose)
    LOINC
    LP116765-1
    Units
    Beschreibung

    Concomitant Agent, Unit

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0439148 (Unit)
    SNOMED
    767525000
    Frequency
    Beschreibung

    Concomitant Agent, Frequencies

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0439603 (Frequencies (time pattern))
    SNOMED
    272123002
    LOINC
    LP130485-8
    Route
    Beschreibung

    Concomitant Agent, Drug Administration Routes

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0013153 (Drug Administration Routes)
    SNOMED
    410675002
    LOINC
    LP40261-7
    Date started
    Beschreibung

    Concomitant Medication Start Date

    Datentyp

    date

    Alias
    UMLS CUI [1]
    C2826734 (Concomitant Medication Start Date)
    Check if started Pre- study
    Beschreibung

    Concomitant Medication Start Date

    Datentyp

    boolean

    Alias
    UMLS CUI [1]
    C2826734 (Concomitant Medication Start Date)
    Date stopped
    Beschreibung

    Concomitant Medication End Date

    Datentyp

    date

    Alias
    UMLS CUI [1]
    C2826744 (Concomitant Medication End Date)
    Check if continued Post- study
    Beschreibung

    Concomitant Agent, Continuous

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C0549178 (Continuous)
    SNOMED
    255238004
    LOINC
    LA16902-1
    Conditions treated/ indication
    Beschreibung

    Concomitant Agent, Indication

    Datentyp

    text

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C3146298 (Indication)
    Was drug administered for an adverse event?
    Beschreibung

    Concomitant Agent, Indication, Adverse Event

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C2347852 (Concomitant Agent)
    UMLS CUI [1,2]
    C3146298 (Indication)
    UMLS CUI [1,3]
    C0877248 (Adverse event)
    LOINC
    MTHU014542
    Zum Seitenanfang zurückkehren

    Ähnliche Modelle

    Concomitant Medication

    1 Formulare
    1. StudyEvent: ODM
      1. Concomitant Medication
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    Administrative Data
    C1320722 (UMLS CUI-1)
    Clinical Trial Subject Unique Identifier
    Item
    Subject number
    integer
    C2348585 (UMLS CUI [1])
    Item Group
    Concomitant Medications
    C2347852 (UMLS CUI-1)
    Concomitant Agent, During, Clinical Trials
    Item
    Were any concomitant medications taken by the subject during the study?
    boolean
    C2347852 (UMLS CUI [1,1])
    C0347984 (UMLS CUI [1,2])
    C0008976 (UMLS CUI [1,3])
    Concomitant Agent, Medication name
    Item
    Drug (Trade name preferred)
    text
    C2347852 (UMLS CUI [1,1])
    C2360065 (UMLS CUI [1,2])
    Concomitant Agent, Medication dose
    Item
    Dose
    text
    C2347852 (UMLS CUI [1,1])
    C3174092 (UMLS CUI [1,2])
    Concomitant Agent, Unit
    Item
    Units
    text
    C2347852 (UMLS CUI [1,1])
    C0439148 (UMLS CUI [1,2])
    Concomitant Agent, Frequencies
    Item
    Frequency
    text
    C2347852 (UMLS CUI [1,1])
    C0439603 (UMLS CUI [1,2])
    Concomitant Agent, Drug Administration Routes
    Item
    Route
    text
    C2347852 (UMLS CUI [1,1])
    C0013153 (UMLS CUI [1,2])
    Concomitant Medication Start Date
    Item
    Date started
    date
    C2826734 (UMLS CUI [1])
    Concomitant Medication Start Date
    Item
    Check if started Pre- study
    boolean
    C2826734 (UMLS CUI [1])
    Concomitant Medication End Date
    Item
    Date stopped
    date
    C2826744 (UMLS CUI [1])
    Concomitant Agent, Continuous
    Item
    Check if continued Post- study
    boolean
    C2347852 (UMLS CUI [1,1])
    C0549178 (UMLS CUI [1,2])
    Concomitant Agent, Indication
    Item
    Conditions treated/ indication
    text
    C2347852 (UMLS CUI [1,1])
    C3146298 (UMLS CUI [1,2])
    Concomitant Agent, Indication, Adverse Event
    Item
    Was drug administered for an adverse event?
    boolean
    C2347852 (UMLS CUI [1,1])
    C3146298 (UMLS CUI [1,2])
    C0877248 (UMLS CUI [1,3])
    Zum Seitenanfang zurückkehren 

    Hilfe

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video